123I-iomazenil

123I-碘西尼

Report date: 2025/11/25 15:52:59

NME

Base Information

Drug Name123I-iomazenil

Drug Alias Nameiodine-123-iomazenilBenzodine

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Iodine > 123IRadiation-emitting products > Radionuclide Drug Conjugates +[5]

Mechanisms of ActionGamma-aminobutyric acid A receptor antagonists

TargetsGamma-aminobutyric acid A receptor

Therapy Area/IndicationsEpilepsy

Global Approved IndicationsEpilepsy

Approved Indications in ChinaN/A

Original Approved Country/TerritorySwitzerland

Original Approved Date1991/09/27

Country/TerritorySwitzerlandJapan

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesF. Hoffmann-La Roche Ltd

China Registration ClassN/A

Develop Information

Active CompaniesNihon Medi-Physics Co Ltd

Inactive CompaniesN/A

Active IndicationsEpilepsy

Inactive IndicationsN/A

Other Information

ATC CodeN03AX11